Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements Of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income / Loss
Treasury Stock
Total
Beginning balance, shares at Dec. 31, 2019 2,774,394 6,092,432          
Beginning balance, value at Dec. 31, 2019 $ 2,774 $ 6,092 $ 188,240,451 $ (166,008,620) $ 253,734 $ (5,281,180) $ 17,213,251
Share-based expense 165,598 165,598
Exercise of purchase warrants, shares 219,474          
Exercise of purchase warrants, value $ 219 (219)
Net loss (1,179,429) (1,179,429)
Ending balance, shares at Mar. 31, 2020 2,774,394 6,311,906          
Ending balance, value at Mar. 31, 2020 $ 2,774 $ 6,311 188,405,830 (167,188,049) 253,734 (5,281,180) 16,199,420
Beginning balance, shares at Dec. 31, 2020 2,774,394 8,772,198          
Beginning balance, value at Dec. 31, 2020 $ 2,774 $ 8,771 194,133,511 (176,902,086) 253,734 (5,281,180) 12,215,524
Share-based expense 76,284 76,284
Exercise of purchase warrants, shares 1,485          
Exercise of purchase warrants, value $ 1 (1)
Net loss (1,345,945) (1,345,945)
Ending balance, shares at Mar. 31, 2021 2,774,394 8,773,683          
Ending balance, value at Mar. 31, 2021 $ 2,774 $ 8,772 $ 194,209,794 $ (178,248,031) $ 253,734 $ (5,281,180) $ 10,945,863